Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$661K Sell
1,569
-1
-0.1% -$399 0.12% 144
2026
Q2
$569K Sell
1,570
-861
-35% -$295K 0.1% 199
2026
Q1
$855K Buy
2,431
+1,460
+150% +$520K 0.18% 92
2025
Q4
$318K Buy
971
+184
+23% +$58.4K 0.07% 307
2025
Q3
$222K Buy
+787
New +$228K 0.09% 246
2025
Q2
– Sell
-744
Closed -$232K – 293
2025
Q1
$232K Buy
+744
New +$220K 0.14% 140

Other funds holding AMGN

Abel Hall LLC's AMGN Position: Q3 2026 in Review

Abel Hall LLC reduced its Amgen (AMGN) stake by 0.06% in Q3 2026, selling an estimated $399 and leaving 1,569 shares worth $661K. The position accounts for 0.12% of the portfolio, ranked #144.

Abel Hall LLC first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $855K in Q1 2026. 1,235 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Abel Hall LLC held 1,569 shares of Amgen worth $661K as of Q3 2026.
  • Abel Hall LLC sold 1 Amgen share in Q3 2026, an estimated $399.
  • Amgen made up 0.12% of Abel Hall LLC's portfolio in Q3 2026, its #144 holding.
  • Abel Hall LLC first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Abel Hall LLC's Amgen position peaked at $855K in Q1 2026.
  • 1,235 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.